Functional status-Class II: Mildly disabled Posts on Medivizor
Navigation Menu

Functional status-Class II: Mildly disabled Posts on Medivizor

Searching for patients with rheumatoid arthritis to switch to a rituximab biosimilar

Searching for patients with rheumatoid arthritis to switch to a rituximab biosimilar

Posted by on Sep 6, 2020 in Rheumatoid Arthritis | 0 comments

In a nutshell This phase 3 trial will investigate the safety and effectiveness of switching from rituximab (Rituxan/Mabthera) to DRL_RI in patients with rheumatoid arthritis (RA). The main outcome will be the rate of side effects and anti-drug drug antibodies (ADAs). This study is recruiting at several locations in the United...

Read More

Achieving stable low disease activity with adalimumab plus methotrexate

Achieving stable low disease activity with adalimumab plus methotrexate

Posted by on Apr 12, 2014 in Rheumatoid Arthritis | 0 comments

In a nutshell This trial compared the efficacy of 2 treatment regimens: methotrexate (MTX) monotherapy versus dual therapy of MTX plus biological drug in patients with early rheumatoid arthritis. Some background Rheumatoid arthritis (RA) is an autoimmune disease that occurs when the immune system mistakenly attacks the body’s own tissues, in...

Read More